期刊文献+

唑来膦酸治疗高龄骨质疏松性不稳定转子间骨折患者的临床效果观察 被引量:1

Clinical efficacy of zoledronic acid in the treatment of osteoporotic unstable intertrochanteric fracture in the elderly
下载PDF
导出
摘要 目的分析唑来膦酸治疗高龄骨质疏松性不稳定转子间骨折临床效果观察。方法选取丽水市中心医院2014年2月~2016年7月收治的100例高龄骨质疏松性不稳定转子间骨折患者为研究对象,随机分为对照组和实验组,每组患者为50例。对照组进行常规治疗(鲑降钙素),实验组患者进行唑来膦酸治疗,比较分析2组患者相关临床指标。结果经过对应的治疗后,实验组与对照组VAS评分分别为(0.36±0.42)与(0.34±0.40),差异无统计学意义。对照组髋关节功能优良率为82.0%,实验组髋关节功能优良率为80.0%,差异无统计学意义。另外,2组患者骨折愈合时间与并发症发生情况差异均无统计学意义。术后1年,实验组患者髋部骨密度与腰椎骨密度分别为(0.78±0.05)g/cm^2与(0.85±0.06)g/cm^2显著高于对照组,差异具有统计学意义(P〈0.05)。结论唑来膦酸治疗高龄骨质疏松性不稳定转子间骨折临床效果较为显著,能够在很大程度上提高患者骨密度,对关节恢复并无影响。 Objective To study and analyze the clinical efficacy of zoledronic acid in the treatment of osteoporotic intertrochanteric fracture in elderly patients.Methods 100 elderly patients with osteoporotic unstable intertrochanteric fracture treated in our hospital from February 2014 to July 2016 were selected and randomly divided into the control group and the experimental group.There were 50 patients in each group.The control group received routine treatment(calcitonin),and the experimental group was treated with zoledronic acid.The clinical indicators of the two groups were compared and analyzed.Results After the corresponding treatment,the VAS scores of the experimental group and the control group were(0.36±0.42) and(0.34±0.40),and there was no statistical significance.The excellent rate of hip joint function was 82% in the control group,and the excellent and good rate of hip joint function in the experimental group was 80%,which was not statistically significant.In addition,there were no statistically significant differences in fracture healing time and complications between the two groups.After 1 years,the hip bone mineral density and the lumbar vertebral bone mineral density were(0.78±0.05) g/cm^2,and(0.85±0.06) g/cm^2 were significantly higher than those in the control group,with statistical significance(P〈0.05).Conclusion Zoledronic acid in the treatment of senile osteoporotic unstable intertrochanteric fracture clinical effect is remarkable,can increase bone mineral density in a large extent,the joint recovery had no effect,has clinical significance.
出处 《中国生化药物杂志》 CAS 2017年第10期83-84,共2页 Chinese Journal of Biochemical Pharmaceutics
基金 丽水市科技计划高层次人才项目(2016RC19) 浙江省医药卫生科技计划项目(2015KYB450)
关键词 唑来膦酸 骨质疏松性不稳定转子间骨折 高龄 zoledronic acid osteoporotic unstable intertrochanteric fracture advanced age
  • 相关文献

参考文献5

二级参考文献45

  • 1刘忠厚,杨定焯,朱汉民,王洪复,张柳,唐海,赵燕玲.中国人原发性骨质疏松症诊断标准(试行)[J].中国骨质疏松杂志,1999,5(1):1-3. 被引量:244
  • 2程建秋.骨质疏松性骨折的危险因素与干预措施[J].中国骨质疏松杂志,2005,11(4):488-489. 被引量:8
  • 3郑得志,于建华,杨有庚,周连星,李卫哲,林枫松.股骨转子间骨折动力髋螺钉内固定失败的危险因素[J].中华创伤杂志,2006,22(2):129-132. 被引量:109
  • 4邓永忠,禹宝庆,高文魁,李智刚,王德元,王伟.股骨近端髓内钉系统治疗股骨转子间骨折48例[J].中华创伤杂志,2006,22(8):635-636. 被引量:4
  • 5Retomaz,Duque G. Osteoprosis in the elderly. Presse Med,2006, 35 : 1547-1556.
  • 6Barton TM, Gleeson R, Topliss C, et al. A comparison of the long gamma nail with the sliding hip screw for the treatment of AO/OTA 31 - A2 fractures of the proximal part of the femur: a prospective randomized triM. J Bone Joint Surg (Am), 2010, 92(4) :792 - 798.
  • 7Mereddy P, Kamath S, Ramakrishnan M, et al. The AO/ASIF proximal femoral nail antirotation (PFNA) : a new design for the treatment of unstable proximal femoral fractures. Injury, 2009, 40 (4) :428 -432.
  • 8Evans EM. The treatment of trochanteric fractures of the femur. J Bone Joint Surg ( Br), 1949, 31 (2) : 190 - 203.
  • 9Mullerler ME, Nazarian S, Koch P. The Comprehensive classifica- tion of fractures of the long bones. 1 st ed. New York: Springer Verlag, 1990 : 118 - 121.
  • 10Simmermacher RK, Ljungqvist J, Bail H, et al. The new proximal femoral nail antimtation (PFNA) in daily practice: results of a muhicentre clinical study. Injury, 2008, 39 ( 8 ) :932 - 939.

共引文献111

同被引文献8

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部